Healwell AI (AIDX) Investor presentation summary

Business overview and reach

• Healthcare software spans data interoperability and infrastructure, AI-enabled clinical decision support, and patient identification tools.

• Serves 70+ public and private healthcare systems and 8 of the 10 largest pharma companies; reported access to 150M+ patient lives across 11 countries.

• Q2 annualized revenue run-rate of ~$132M, with 500+ employees and headquarters in Toronto.

• Exclusive strategic partnership with WELL Health provides compliant access to its healthcare data ecosystem; WELL reported ~8M yearly patient visits and 5,000+ providers as of June 30, 2026.

Technology and commercial traction

• AI pilots target rare disease, chronic kidney disease, cardiovascular disease, and oncology, including cancer staging for complex head and neck cancers.

• SMARTSearch applies NLP-driven queries to structured and unstructured EMR data; 80% of critical patient insights are described as buried in those records.

• 47 peer-reviewed publications, Prix Galien USA 2024 winner, and published studies reporting up to 100x efficiency improvement versus manual chart review.

• Orion Health distribution spans 70+ enterprise customers across 11 countries; more than 30 MSAs with leading pharma include 8 of the world’s top 10.

• AI and data science contribute 10% of revenue with ~60% gross margin; healthcare software contributes 90%, recurring revenue, 55–60% gross margin, and positive EBITDA.

Financial performance

• Revenue increased from C$7.3M in 2023 to C$39.0M in 2024 and C$103.8M in 2025.

• Adjusted EBITDA improved from C$-15.9M in 2023 to C$-7.9M in 2024 and C$2.3M in 2025.